(Q30240839)

12 June 2017

1 reference

title

Genetic determinants of myocardial dysfunction (English)

1 reference

12 June 2017

Xianchi Li

1

1 reference

PubMed ID

27872154

12 June 2017

Peiying Zhang

series ordinal

2

1 reference

PubMed ID

27872154

12 June 2017

language of work or name

English

0 references

publication date

21 November 2016

1 reference

Journal of Medical Genetics

12 June 2017

1 reference

12 June 2017

54

1 reference

12 June 2017

1-10

1 reference

12 June 2017

1

1 reference

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

12 June 2017

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Heart failure and kidney dysfunction: epidemiology, mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Sibling risk of hospitalization for heart failure - A nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Epigenetics of the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Epigenetic Regulation in Heart Failure: Part I RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Epidemiology and risk profile of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Epidemiology and aetiology of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Genetics and heart failure: a concise guide for the clinician

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Obesity and the risk of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Obesity paradox in heart failure: statistical artifact, or impetus to rethink clinical practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Dilated cardiomyopathy: the complexity of a diverse genetic architecture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Genetic mutations and mechanisms in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Genetics of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Proteomic identification of putative biomarkers for early detection of sudden cardiac death in a family with a LMNA gene mutation causing dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Lamin A/C deficiency as a cause of familial dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Truncations of titin causing dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Altered myocardial calcium cycling and energetics in heart failure--a rational approach for disease treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Update 2011: clinical and genetic issues in familial dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Homozygosity mapping and exome sequencing reveal GATAD1 mutation in autosomal recessive dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Molecular profiling of dilated cardiomyopathy that progresses to heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Decreased levels of BAG3 in a family with a rare variant and in idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Cardiac troponin T lysine 210 deletion in a family with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Cardiac myosin missense mutations cause dilated cardiomyopathy in mouse models and depress molecular motor function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Cardiac titin: structure, functions and role in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

A Review of the Giant Protein Titin in Clinical Molecular Diagnostics of Cardiomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Role of Titin Missense Variants in Dilated Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

The Rapidly Evolving Role of Titin in Cardiac Physiology and Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

The Genetic Challenges and Opportunities in Advanced Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Shared genetic causes of cardiac hypertrophy in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Sarcomere gene mutations in hypertrophy and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

The pathology of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Guideline of transthyretin-related hereditary amyloidosis for clinicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Hypertrophic Cardiomyopathy: Cell-to-Cell Imbalance in Gene Expression and Contraction Force as Trigger for Disease Phenotype Development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

The management of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Mitochondrial disorders: prevalence, myths and advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Cardiac manifestations in oxidative phosphorylation disorders of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Decreased Peripheral Mitochondrial DNA Copy Number is Associated with the Risk of Heart Failure and Long-term Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Disorders of fatty acid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study from 187 patients. Complementary data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Adult presentations of medium-chain acyl-CoA dehydrogenase deficiency (MCADD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Glycogen storage diseases presenting as hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Heart failure in congenital heart disease: the role of genes and hemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Congenital heart disease caused by mutations in the transcription factor NKX2-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Functional characterization of a novel mutation in NKX2-5 associated with congenital heart disease and adult-onset cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Genetics of common forms of heart failure: challenges and potential solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Genomic variation associated with mortality among adults of European and African ancestry with heart failure: the cohorts for heart and aging research in genomic epidemiology consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Loss-of-function DNA sequence variant in the CLCNKA chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Common variants in HSPB7 and FRMD4B associated with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Genome-wide association study of cardiac structure and systolic function in African Americans: the Candidate Gene Association Resource (CARe) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Novel Therapies for Heart Failure　- Where Do They Stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Association of Parental Heart Failure with Risk of Heart Failure in Offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Executive Summary: Heart Disease and Stroke Statistics—2010 Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Body composition and prognosis in chronic systolic heart failure: the obesity paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Structural and functional studies of titin’s fn3 modules reveal conserved surface patterns and binding to myosin S1 - a possible role in the frank-starling mechanism of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJMEDGENET-2016-104308

10.1136/JMEDGENET-2016-104308

21 January 2018

Identifiers

DOI

1 reference

12 June 2017

1 reference